Application Prospect of Mannabidiol in Medicine

Hong-yan JIANG; Rui-lin ZHANG; Yan CAO; Hai-ying WU; Ping LI

doi:10.12259/j.issn.2095-610X.S20210208

Volume 42 Issue 2

Mar. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2021 > 42(2): 147-152

Hong-yan JIANG, Rui-lin ZHANG, Yan CAO, Hai-ying WU, Ping LI. Application Prospect of Mannabidiol in Medicine[J]. Journal of Kunming Medical University, 2021, 42(2): 147-152. doi: 10.12259/j.issn.2095-610X.S20210208

Citation:

Hong-yan JIANG, Rui-lin ZHANG, Yan CAO, Hai-ying WU, Ping LI. Application Prospect of Mannabidiol in Medicine[J]. Journal of Kunming Medical University, 2021, 42(2): 147-152. doi: 10.12259/j.issn.2095-610X.S20210208

Citation:

PDF( 615 KB)

Application Prospect of Mannabidiol in Medicine

doi: 10.12259/j.issn.2095-610X.S20210208

1.
Dept. of Human Anatomy and Histology and Embryology，Kunming Medical University
2.
Dept. of Toxicology，School of Forensic Medicine
3.
Dept. of Emergency Medicine，First Affiliated Hospital，Kunming Yunnan 650032
4.
Dept. of Pathology，Suining Central Hospital，Suining Sichuan，China

Received Date: 2020-11-14
Publish Date: 2021-03-05

Abstract

Abstract

The main components of cannabis with medicinal value are Δ9-tetrahydrocannabinol（Δ9-THC）and cannabidiol（CBD）, of which CBD cannot directly activate cannabinoid type 1 receptor（CB1R）and cannabinoid type 2 receptors. Body（CB2R）does not have psychoactive and drug dependence, and its safety is relatively high. CBD, as the main cannabinoid extract, has proven to have analgesic, sedative, anti-inflammatory, anti-convulsant, sleep-improving, anti-anxiety, anti-psychotic, anti-rheumatic, skin barrier, anti-apoptotic and neuroprotective effects. This review aims to summarize the application status of CBD in the treatment of clinical diseases, and provide new ideas for the future application of CBD-related drugs in the treatment of epilepsy, neuropathic pain, anxiety and depression, tumors, skin, and metabolism-related diseases.
- Cannabidiol,
- Clinical application,
- Neuroprotection

FullText(HTML)

References(49)

References

[1]	Devinsky O,Marsh E,Friedman D,et al. Cannabidiol in patients with treatment-resistant epilepsy:an open-label interventional trial[J]. The Lancet Neurology,2016,15(3):270-278. doi: 10.1016/S1474-4422(15)00379-8
[2]	Stockings E,Zagic D,Campbell G,et al. Evidence for cannabis and cannabinoids for epilepsy:a systematic review of controlled and observational evidence[J]. Journal of Neurology,Neurosurgery,and Psychiatry,2018,89(7):741-753. doi: 10.1136/jnnp-2017-317168
[3]	Rosenberg E C,Louik J,Conway E,et al. Quality of life in childhood epilepsy in pediatric patients enrolled in a prospective,open-label clinical study with cannabidiol[J]. Epilepsia,2017,58(8):e96-e100. doi: 10.1111/epi.13815
[4]	Ferreira-junior N C,Campos A C,Guimarães F S,et al. Biological bases for a possible effect of cannabidiol in Parkinson's disease[J]. Revista Brasileira de Psiquiatria (Sao Paulo,Brazil :1999),2020,42(2):218-224. doi: 10.1590/1516-4446-2019-0460
[5]	Junior N C F,Dos-santos-pereira M,Guimarães F S,et al. Cannabidiol and cannabinoid compounds as potential strategies for treating parkinson's disease and L-DOPA-Induced dyskinesia[J]. Neurotoxicity Research,2020,37(1):12-29. doi: 10.1007/s12640-019-00109-8
[6]	Balash Y,Bar-lev schleider L,Korczyn A D,et al. Medical cannabis in parkinson disease:Real-Life patients' experience[J]. Clinical Neuropharmacology,2017,40(6):268-272. doi: 10.1097/WNF.0000000000000246
[7]	Khan F,Amatya B. Rehabilitation in multiple sclerosis:A systematic review of systematic reviews[J]. Archives of Physical Medicine and Rehabilitation,2017,98(2):353-367. doi: 10.1016/j.apmr.2016.04.016
[8]	López-sendón moreno J L,García caldentey J,Trigo cubillo P,et al. A double-blind,randomized,cross-over,placebo-controlled,pilot trial with Sativex in Huntington's disease[J]. Journal of Neurology,2016,263(7):1390-1400. doi: 10.1007/s00415-016-8145-9
[9]	Clément T,Rodriguez-grande B,Badaut J. Aquaporins in brain edema[J]. Journal of Neuroscience Research,2020,98(1):9-18. doi: 10.1002/jnr.24354
[10]	Hayakawa K,Irie K,Sano K,et al. Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism[J]. Biological & Pharmaceutical Bulletin,2009,32(9):1538-1544.
[11]	高兵兵,吴月奎,马建华,等. 大麻二酚对急性脑出血小鼠的神经保护作用及其机制[J]. 山东医药,2017,57(4):34-36. doi: 10.3969/j.issn.1002-266X.2017.04.010
[12]	Mandolini G M,Lazzaretti M,Pigoni A,et al. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders:a critical overview[J]. Epidemiology and Psychiatric Sciences,2018,27(4):327-335. doi: 10.1017/S2045796018000239
[13]	Zanelati T V,Biojone C,Moreira F A,et al. Antidepressant-like effects of cannabidiol in mice:possible involvement of 5-HT1A receptors[J]. British Journal of Pharmacology,2010,159(1):122-128. doi: 10.1111/j.1476-5381.2009.00521.x
[14]	Ceskova E,Silhan P. Novel treatment options in depression and psychosis[J]. Neuropsychiatric Disease and Treatment,2018,14(1):741-747.
[15]	Silote G P,Sartim A,Sales A,et al. Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms[J]. Journal of Chemical Neuroanatomy,2019,98(4):104-116.
[16]	Statter M B,Hirschl R B,Coran A C. Inflammatory bowel disease[J]. Pediatric Clinics of North America,1993,40:1213-1231.
[17]	De filippis D,Iuvone T,D'amico A,et al. Effect of cannabidiol on sepsis-induced motility disturbances in mice:involvement of CB receptors and fatty acid amide hydrolase[J]. Neurogastroenterology and Motility :The official Journal of the European Gastrointestinal Motility Society,2008,20(8):919-927. doi: 10.1111/j.1365-2982.2008.01114.x
[18]	Chen G Y,Cao H X,Li F,et al. New risk-scoring system including non-alcoholic fatty liver disease for predicting incident type 2 diabetes in east China:Shanghai baosteel cohort[J]. Journal of diabetes investigation,2016,7(2):206-211. doi: 10.1111/jdi.12395
[19]	Wang Y,Mukhopadhyay P,Cao Z,et al. Cannabidiol attenuates alcohol-induced liver steatosis,metabolic dysregulation,inflammation and neutrophil-mediated injury[J]. Scientific Reports,2017,7(1):12064. doi: 10.1038/s41598-017-10924-8
[20]	郭蓉,陈璇,郭鸿彦. 四氢大麻酚和大麻二酚的药理研究进展[J]. 天然产物研究与开发,2017,29(8):1449-1453.
[21]	Wang Y,Mukhopadhyay P,CAO Z,et al. Cannabidiol protects against chronic plus binge alcohol induced liver injury by modulating neutrophil infiltration,E selectin,inflammation and oxidative/nitrative stress[J]. Free Radical Biology & Medicine,2014,76(12):S88.
[22]	Ignatowska-jankowska B,Jankowski M M,Swiergiel A H. Cannabidiol decreases body weight gain in rats:involvement of CB2 receptors[J]. Neuroscience Letters,2011,490(1):82-84. doi: 10.1016/j.neulet.2010.12.031
[23]	Yang L,Rozenfeld R,Wu D,et al. Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy[J]. Free Radic Biol Med,2014,68(3):260-267.
[24]	Silvestri C,Paris D,Martella A,et al. Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis[J]. Journal of Hepatology,2015,62(6):1382-1390. doi: 10.1016/j.jhep.2015.01.001
[25]	陈瑞,高晓刚,张雷,等. 大麻二酚对大鼠非酒精性脂肪肝的治疗作用及机制[J]. 解放军医学杂志,2017,42(6):515-519. doi: 10.11855/j.issn.0577-7402.2017.06.07
[26]	常丽,李建军,黄思齐,等. 植物大麻活性成分及其药用研究概况[J]. 生命的化学,2018,38(2):273-280.
[27]	韦凤,涂冬萍,王柳萍. 火麻仁食用开发和药理作用研究进展[J]. 中国老年学,2015,35(12):3486-3488.
[28]	Oláh A,Tóth B I,Borbíró I,et al. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes[J]. The Journal of Clinical Investigation,2014,124(9):3713-3724. doi: 10.1172/JCI64628
[29]	Petrosino S,Verde R,Vaia M,et al. Anti-inflammatory properties of cannabidiol,a nonpsychotropic cannabinoid,in experimental allergic contact dermatitis[J]. The Journal of Pharmacology and Experimental Therapeutics,2018,365(3):652-663. doi: 10.1124/jpet.117.244368
[30]	Wilkinson J D,Williamson E M. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis[J]. Journal of Dermatological Science,2007,45(2):87-92. doi: 10.1016/j.jdermsci.2006.10.009
[31]	Walsh S K,Hepburn C Y,Kane K A,et al. Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion[J]. British Journal of Pharmacology,2010,160(5):1234-1242. doi: 10.1111/j.1476-5381.2010.00755.x
[32]	Durst R,Danenberg H,Gallily R,et al. Cannabidiol,a nonpsychoactive cannabis constituent,protects against myocardial ischemic reperfusion injury[J]. American Journal of Physiology Heart and Circulatory Physiology,2007,293(6):H3602-3607. doi: 10.1152/ajpheart.00098.2007
[33]	Feng Y,Chen F,Yin T,et al. Pharmacologic effects of cannabidiol on acute reperfused myocardial infarction in rabbits:Evaluated with 3.0T cardiac magnetic resonance imaging and histopathology[J]. Journal of Cardiovascular Pharmacology,2015,66(4):354-363. doi: 10.1097/FJC.0000000000000287
[34]	Stanley C P,Hind W H,O'sullivan S E. Is the cardiovascular system a therapeutic target for cannabidiol[J]. British Journal of Clinical Pharmacology,2013,75(2):313-322. doi: 10.1111/j.1365-2125.2012.04351.x
[35]	孙姣卓,王雄,张萍. 大麻二酚对大鼠心肌缺血/再灌注损伤的保护作用和机制[J]. 中西医结合心脑血管病杂志,2016,14(2):133-137. doi: 10.3969/j.issn.1672-1349.2016.02.008
[36]	Blair R E,Deshpande L S,Delorenzo R J. Cannabinoids:is there a potential treatment role in epilepsy[J]. Expert Opinion on Pharmacotherapy,2015,16(13):1911-1914. doi: 10.1517/14656566.2015.1074181
[37]	Ribeiro A,Ferraz-de-paula V,Pinheiro M L,et al. Cannabidiol,a non-psychotropic plant-derived cannabinoid,decreases inflammation in a murine model of acute lung injury:role for the adenosine A(2A) receptor[J]. European Journal of Pharmacology,2012,678(1-3):78-85. doi: 10.1016/j.ejphar.2011.12.043
[38]	叶程龙余,莫斯喻,等. 大麻二酚对应激大鼠肺部损伤的预防保护作用[J]. 广东药学院学报,2019,35(2):234-237.
[39]	JAcobsson S O,Rongård E,Stridh M,et al. Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability[J]. Biochemical Pharmacology,2000,60(12):1807-1813. doi: 10.1016/S0006-2952(00)00492-5
[40]	Massi P,Vaccani A,Bianchessi S,et al. The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells[J]. Cellular and Molecular Life Sciences :CMLS,2006,63(17):2057-2066. doi: 10.1007/s00018-006-6156-x
[41]	Shrivastava A,Kuzontkoski P M,Groopman J E,et al. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy[J]. Molecular Cancer Therapeutics,2011,10(7):1161-1172. doi: 10.1158/1535-7163.MCT-10-1100
[42]	Elbaz M,Nasser M W,Ravi J,et al. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway:novel anti-tumor mechanisms of cannabidiol in breast cancer[J]. Molecular Oncology,2015,9(4):906-919. doi: 10.1016/j.molonc.2014.12.010
[43]	Haustein M,Ramer R,Linnebacher M,et al. Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1[J]. Biochemical pharmacology,2014,92(2):312-325. doi: 10.1016/j.bcp.2014.07.014
[44]	Solinas M,Massi P,Cantelmo A R,et al. Cannabidiol inhibits angiogenesis by multiple mechanisms[J]. British Journal of Pharmacology,2012,167(6):1218-1231. doi: 10.1111/j.1476-5381.2012.02050.x
[45]	Simmerman E,Qin X,Yu J C,et al. Cannabinoids as a potential new and novel treatment for melanoma:A pilot study in a murine model[J]. The Journal of Surgical Research,2019,235(3):210-215.
[46]	Chelliah M P,Zinn Z,Khuu P,et al. Self-initiated use of topical cannabidiol oil for epidermolysis bullosa[J]. Pediatric Dermatology,2018,35(4):e224-e227. doi: 10.1111/pde.13545
[47]	Weiss L,Zeira M,Reich S,et al. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice[J]. Autoimmunity,2006,39(2):143-151. doi: 10.1080/08916930500356674
[48]	Weiss L,Zeira M,Reich S,et al. Cannabidiol arrests onset of autoimmune diabetes in NOD mice[J]. Neuropharmacology,2008,54(1):244-249. doi: 10.1016/j.neuropharm.2007.06.029
[49]	Huestis M A,Solimini R,Pichini S,et al. Cannabidiol adverse effects and toxicity[J]. Current Neuropharmacology,2019,17(10):974-989. doi: 10.2174/1570159X17666190603171901

Relative Articles(20)

Relative Articles

[1]	Xiuhua WANG, Zeran HE, Zhihong LI, Huiling WANG, Hongyan SU. Clinical Application Evaluation and Standard，Reasonable Use of Fat Emulsion，Amino Acids （17） and Glucose （11%） Injection. Journal of Kunming Medical University, 2023, 44(3): 138-142. doi: 10.12259/j.issn.2095-610X.S20230318
[2]	Rui CUN, Meiling CHEN. Efficacy and Clinical Application of Flunarizine Combined with Ginkgo damo in Treatment of Senile Vertigo. Journal of Kunming Medical University, 2022, 43(7): 116-120. doi: 10.12259/j.issn.2095-610X.S20220703
[3]	Yang Shu Di , Zhong Yu Li , Liu Ling , Tian Xin . . Journal of Kunming Medical University, 2020, 41(05): 1-6.
[4]	Sun Kong Chun , Chen Xing Long , Yang Can Yu , Yu Hao Fei , Hu Wei Yan , Wang Rui , Shen Bao Chun , Zhang Rong Ping . . Journal of Kunming Medical University, 2020, 41(05): 23-28.
[5]	Ning Jin Mei , Niu Yan , Zhao Shu Bo , Zhu Yuan , Zhu Heng Jie , Tang Yong . . Journal of Kunming Medical University, 2019, 40(01): 74-77.
[6]	Yang Yue, Tao Jian Ping . . Journal of Kunming Medical University, 2019, 40(12): 135-139.
[7]	Wang Xiu Hua , Yang Zhong Ming , Yang Chao , Zhang Guang Yun , Ren Dong Wei , Wang Xue Chang . Evaluation of the Clinical Application of Antineoplastic Drugs in Lincang People's Hospital. Journal of Kunming Medical University, 2017, 38(07): 88-92.
[8]	Deng Li Qiang . Comparison of the Effects of Sevoflurane and Propofol on One Lung Ventilation Induced Ischemia-Reperfusion Injury. Journal of Kunming Medical University,
[9]	Gao Wen Xiu . Clinical Application of Duraphat Fluoride Varnish. Journal of Kunming Medical University,
[10]	Zhou Ying . Clinical Application of the Next-generation Sequencing Technology. Journal of Kunming Medical University,
[11]	Li Jian Gang . . Journal of Kunming Medical University,
[12]	Wang Can Zhi . . Journal of Kunming Medical University,
[13]	Yu Yang . . Journal of Kunming Medical University,
[14]	Li Jian Gang . . Journal of Kunming Medical University,
[15]	Du Xiong . . Journal of Kunming Medical University,
[16]	Zhang Hong Jiang . . Journal of Kunming Medical University,
[17]	Song Chao . . Journal of Kunming Medical University,
[18]	. Clinical Application of Capsule Endoscopy in Gastrointestinal Diseases. Journal of Kunming Medical University,
[19]	. . Journal of Kunming Medical University,
[20]	Sun Jie . . Journal of Kunming Medical University,